Literature DB >> 17200156

Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat.

You-Lin Tain1, Gary Freshour, Anna Dikalova, Kathy Griendling, Chris Baylis.   

Abstract

Chronic kidney disease is accompanied by nitric oxide (NO) deficiency and oxidative stress, which contribute to progression. We investigated whether the antioxidant vitamin E could preserve renal function and NO bioavailability and reduce oxidative stress in the 5/6th nephrectomy (NX) rat model. We studied the following three groups of male Sprague-Dawley rats: sham (n = 6), 5/6 NX control (n = 6), and 5/6 NX treated with vitamin E (5,000 IU/kg chow; n = 5). The 5/6 NX group showed increased severity of glomerulosclerosis vs. sham, and this was ameliorated by vitamin E therapy. Both 5/6 NX groups showed similar elevations in plasma creatinine and proteinuria and decreased 24-h creatinine clearance compared with sham. There was increased NADPH-dependent superoxide production in 5/6 NX rats vs. sham that was prevented by vitamin E. Total NO production was similarly reduced in both 5/6 NX groups. There was unchanged abundance of endothelial nitric oxide synthesis (NOS) in renal cortex and medulla and neuronal (n) NOS in medulla. However, in kidney cortex, 5/6 NX rats had lower nNOS abundance than sham, which was restored by vitamin E. An increased plasma asymmetric dimethylarginine occurred with 5/6 NX associated with decreased renal dimethylarginine dimethylaminohydrolase activity and increased type 1 protein arginine methyltransferase expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200156     DOI: 10.1152/ajprenal.00260.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  29 in total

1.  Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.

Authors:  Jennifer M Sasser; Natasha C Moningka; Tatsiana Tsarova; Chris Baylis
Journal:  Life Sci       Date:  2012-06-19       Impact factor: 5.037

2.  Determination of dimethylarginine dimethylaminohydrolase activity in the kidney.

Authors:  Y-L Tain; C Baylis
Journal:  Kidney Int       Date:  2007-07-25       Impact factor: 10.612

3.  Splice variants of neuronal nitric oxide synthase are present in the rat kidney.

Authors:  Cheryl Smith; Michael Merchant; Andrea Fekete; Ha-Long Nyugen; Paul Oh; You-Lin Tain; Jon B Klein; Chris Baylis
Journal:  Nephrol Dial Transplant       Date:  2008-12-10       Impact factor: 5.992

4.  Different administration schedules of darbepoetin alfa affect oxidized and reduced glutathione levels to a similar extent in 5/6 nephrectomized rats.

Authors:  Péter Monostori; Gabriella F Kocsis; Zsuzsanna Ökrös; Péter Bencsik; Orsolya Czétényi; Zoltán Kiss; Balázs Gellén; Csaba Bereczki; Imre Ocsovszki; Judit Pipis; János Pálóczi; Márta Sárközy; Szilvia Török; Ilona S Varga; István Kiss; Eszter Fodor; Tamás Csont; Péter Ferdinandy; Sándor Túri
Journal:  Clin Exp Nephrol       Date:  2012-12-06       Impact factor: 2.801

Review 5.  Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.

Authors:  António Nogueira; Maria João Pires; Paula Alexandra Oliveira
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

6.  Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.

Authors:  Gin-Fu Chen; Laszlo Wagner; Jennifer M Sasser; Sergey Zharikov; Natasha C Moningka; Chris Baylis
Journal:  Nephrol Dial Transplant       Date:  2010-05-19       Impact factor: 5.992

7.  Endothelial cell transfusion ameliorates endothelial dysfunction in 5/6 nephrectomized rats.

Authors:  Maricica Pacurari; Dongqi Xing; Rob H P Hilgers; Yuan Yuan Guo; Zhengqin Yang; Fadi G Hage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-16       Impact factor: 4.733

8.  Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.

Authors:  Joseph Satriano; Kumar Sharma; Roland C Blantz; Aihua Deng
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

9.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

10.  In vivo renal arginine release is impaired throughout development of chronic kidney disease.

Authors:  Gin-Fu Chen; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.